Healthcare Value Capital’s Quest Diagnostics DGX Stock Holding History

Healthcare Value Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-66,208	Closed	-$5.6M	–	23
2016 Q3	$5.6M	Hold	66,208	–	–	8.87%	4
2016 Q2	$5.39M	Hold	66,208	–	–	6.53%	5
2016 Q1	$4.73M	Hold	66,208	–	–	6.95%	6
2015 Q4	$4.71M	Hold	66,208	–	–	7.79%	5
2015 Q3	$4.07M	Hold	66,208	–	–	5.8%	6
2015 Q2	$4.8M	Sell	66,208 -11,000	-14%	-$812K	5.04%	8
2015 Q1	$5.93M	Hold	77,208	–	–	6.47%	6
2014 Q4	$5.18M	Hold	77,208	–	–	9.46%	4
2014 Q3	$4.68M	Hold	77,208	–	–	4.52%	11
2014 Q2	$4.53M	Hold	77,208	–	–	3.8%	9
2014 Q1	$4.47M	Hold	77,208	–	–	2.93%	11
2013 Q4	$4.13M	Buy	77,208 +10,000	+15%	+$593K	3.03%	12
2013 Q3	$4.15M	Hold	67,208	–	–	3.63%	10
2013 Q2	$4.08M	Buy	+67,208	New	+$4M	2.95%	8

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Healthcare Value Capital's DGX Position: Q4 2016 in Review

Healthcare Value Capital sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 66,208 shares — an estimated $5.6M sold.

Healthcare Value Capital first reported a position in DGX in Q2 2013 and held it in 14 quarters. The position peaked at $5.93M in Q1 2015. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

Healthcare Value Capital reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
Healthcare Value Capital sold 66,208 Quest Diagnostics shares in Q4 2016, an estimated $5.6M.
Healthcare Value Capital first reported a position in Quest Diagnostics in Q2 2013 and held it in 14 quarters.
Healthcare Value Capital's Quest Diagnostics position peaked at $5.93M in Q1 2015.
597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Healthcare Value Capital's 13F filing for Q4 2016, filed 10 Feb 2017.